VSee Health (VSEE)
NASDAQ:VSEE
Want to see VSEE full AI Analyst Report?
VSEE Stock Chart & Stats
$0.38
-$0.02(-1.82%)
At close: 4:00 PM EST
$0.38
-$0.02(-1.82%)
Day’s Range― - ―
52-Week Range$0.19 - $2.52
Previous CloseN/A
Volume71.92K
Average Volume (3M)1.90M
Market Cap
$11.29M
Enterprise Value$1.05M
Total Cash (Recent Filing)$5.27M
Total Debt (Recent Filing)$2.44M
Price to Earnings (P/E)―
Beta0.35
Next Earnings
Sep 28, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding47,299,420
10 Day Avg. Volume5,577,105
30 Day Avg. Volume1,899,699
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)1.38
Price to Sales (P/S)0.52
P/FCF Ratio-2.17
Enterprise Value/Market Cap0.09
Enterprise Value/Revenue0.07
Enterprise Value/Gross Profit0.14
Enterprise Value/Ebitda-0.11
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.24
Revenue Forecast (FY)$21.60M
Bulls Say, Bears Say
Bulls Say
Revenue Growth And Gross MarginSustained high revenue growth combined with roughly 50% gross margins points to a scalable software-centric business model with durable unit economics. This supports reinvestment in product and sales, and provides a structural path to improving operating leverage if growth continues and OPEX control follows.
Improved Capitalization And Manageable LeverageReturn to positive equity and a relatively low debt-to-equity ratio reduces short-term insolvency risk and increases financing optionality. Improved capitalization gives the company more runway to execute strategic initiatives and reduces the immediacy of rescue financings, a durable improvement to the firm’s financial resilience.
Strategic Managed-services Tie-up And Equity StakeA multi-year managed services agreement plus a 10% equity stake aligns incentives with a national prescription fulfillment partner, adding recurring service revenue, operational integration capabilities, and go-to-market synergies. This structurally expands product scope and strengthens enterprise value proposition over the medium term.
Bears Say
Persistent Negative Cash FlowSustained negative operating and free cash flow constrains strategic flexibility and forces reliance on external funding or equity issuance to support growth. Over several quarters this persistent cash burn increases dilution risk, limits ability to self‑fund investments, and weakens resilience to downturns.
Deep And Persistent UnprofitabilityVery large negative net margins indicate the company has not yet crossed the profitability threshold; continued high losses undermine return prospects for investors and create pressure to materially improve margins or scale further. Structural profitability risk remains until operating losses are consistently eliminated.
Authorized Warrant-linked Equity IssuanceAuthorization to issue a large block of shares tied to warrants materially increases future dilution risk and signals reliance on equity-based financing. This structural change can reduce per-share economics long-term and may be needed to fund ongoing cash deficits absent sustained positive cash generation.
VSee Health News
VSEE FAQ
What was VSee Health’s price range in the past 12 months?
VSee Health lowest stock price was $0.19 and its highest was $2.52 in the past 12 months.
What is VSee Health’s market cap?
VSee Health’s market cap is $11.29M.
When is VSee Health’s upcoming earnings report date?
VSee Health’s upcoming earnings report date is Sep 28, 2026 which is in 165 days.
How were VSee Health’s earnings last quarter?
Currently, no data Available
Is VSee Health overvalued?
According to Wall Street analysts VSee Health’s price is currently Overvalued.
Does VSee Health pay dividends?
VSee Health does not currently pay dividends.
What is VSee Health’s EPS estimate?
VSee Health’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does VSee Health have?
VSee Health has 47,299,420 shares outstanding.
What happened to VSee Health’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of VSee Health?
Currently, no hedge funds are holding shares in VSEE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
VSee Health
VSee Health, Inc. provides telehealth care solutions. The company offers iDoc Telehealth solutions that treat and coordinate care for acutely ill patients in the neurointensive care, cardiac intensive care, and intensive care units for stroke, spinal cord, brain trauma, and other neurological conditions. Its telehealth platform provides a set of building blocks to solve needs of clients. VSee Health, Inc. is headquartered in Newton, Massachusetts.
Technical Analysis
Ownership Overview
11.59% Insiders
0.18% Mutual Funds
1.51% Other Institutional Investors
86.70% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---